Indo Us Bio-Tech Limited (BOM:541304)
India flag India · Delayed Price · Currency is INR
127.35
-4.55 (-3.45%)
At close: Feb 12, 2026

Indo Us Bio-Tech Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
162.6782.4172.450.6349
Depreciation & Amortization
10.9888.264.462.59
Other Amortization
---0.140.14
Loss (Gain) From Sale of Assets
-0.04--0.12
Provision & Write-off of Bad Debts
4.68-0.6---
Other Operating Activities
13.4217.5510.2310.40.37
Change in Accounts Receivable
35.7657.57-42.0141.59-37.29
Change in Inventory
-189.51-248.22-35.56-114.77-27.32
Change in Accounts Payable
-32.2629.91-7.6133.068.1
Change in Other Net Operating Assets
8.4575.55-0.451.515.86
Operating Cash Flow
14.1922.215.2627.031.58
Operating Cash Flow Growth
-36.10%322.52%-80.55%1612.03%-
Capital Expenditures
-8.62-26.1-18.23-39.67-19.53
Sale of Property, Plant & Equipment
----0.1
Investment in Securities
--0.1--
Other Investing Activities
0.70.831.250.030.02
Investing Cash Flow
-7.92-25.28-66.74-54.42-17.79
Short-Term Debt Issued
3.816.287.889.921.17
Long-Term Debt Issued
1.3210.97-2.826.03
Total Debt Issued
5.1227.257.8812.7227.2
Long-Term Debt Repaid
---16.91--
Total Debt Repaid
---16.91--
Net Debt Issued (Repaid)
5.1227.25-9.0312.7227.2
Issuance of Common Stock
--83.7627.09-
Common Dividends Paid
-5.01---1.52-
Other Financing Activities
-14.88-15.1-11.84-11.75-11.65
Financing Cash Flow
-14.7712.1562.8926.5415.55
Miscellaneous Cash Flow Adjustments
--0--0
Net Cash Flow
-8.519.091.41-0.85-0.66
Free Cash Flow
5.57-3.89-12.97-12.64-17.95
Free Cash Flow Margin
0.54%-0.53%-2.10%-2.52%-4.48%
Free Cash Flow Per Share
0.28-0.19-0.67-1.03-1.23
Cash Interest Paid
14.8815.111.8411.7611.66
Cash Income Tax Paid
3.523.113.153.871.38
Levered Free Cash Flow
-68.33-36.06-100.53-157.48-44.53
Unlevered Free Cash Flow
-59.35-27.25-93.51-150.32-37.52
Change in Working Capital
-177.56-85.19-85.63-38.61-50.65
Source: S&P Global Market Intelligence. Standard template. Financial Sources.